IMA901

DB06628InvestigationalVaccines

IMA901 is a vaccine consists of tumor-associated peptides (TUMAPs).

Primary indication
Investigated for use/treatment in kidney cancer.Curator reviewed
Code names
IMA-901

What you can answer from here — as of September 21, 2023

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of IMA901, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In